BioProtect receives FDA’s clearance for its biodegradable balloon for rectal protection during prostate cancer radiation therapy.
The biodegradable balloon is a new-generation spacer designed to provide optimal, consistent, and reproducible protection to the rectum during prostate cancer radiation therapy.
BioProtect’s technology provides better protection to healthy organs and supports dose escalation and hypofractionation, allowing optimizing treatment for almost all men with prostate cancer, even those with high-risk disease.
According to the American Cancer Society, prostate cancer is the second most common cancer among men in the United States, with 288,300 new cases diagnosed in 2023.
